Saturday, December 3, 2022

561.316.3330

Biotechnology News Magazine

FLYY the Next Metaverse

Latest Posts

Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia

Venetoclax is a BCL-2 inhibitor approved by the U.S. Food and Drug Administration (FDA) for treatment of several hematologic cancers, including in combination with azacytidine for elderly patients with AML unable to tolerate the standard of care.

Acer Therapeutics Announces $1.5M Private Placement

The proceeds from the private placement will be used by Acer Therapeutics for working capital and general corporate purposes and, together with Acer’s existing cash and cash equivalents, are expected to be sufficient to fund the Company’s anticipated operating and capital requirements through the fourth quarter of 2022.

AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “The selection of ACI-35.030 for further development is a significant step for this collaboration. Early clinical testing showed that ACI-35.030 was generally well tolerated and induced specific activity against the pathological species of Tau, including the neurotoxic pTau and enriched paired helical filaments (ePHF) species, both of which are closely implicated in Alzheimer’s disease (AD).

TransCode Therapeutics Announces eIND Submission to US FDA for Planned First-in-Human Clinical Trial in Patients with Advanced Solid Tumors

The planned clinical trial is to evaluate TransCode’s lead therapeutic candidate, TTX-MC138, in cancer patients with advanced solid tumors. ​TTX-MC138 is designed to inhibit the pro-metastatic RNA, microRNA-10b, described as the master regulator of metastasis in a number of advanced solid tumors. TransCode Therapeutics believes that TTX-MC138 could be used as a treatment for many of these cancers.

FLYY! What is the purpose of our social network if not to be social? Introducing FLYY! An interactive map that allows you to check-in at your favorite places and connect with everyone within your local community.

Flyy presents real cities in a virtual 3D world that allows you to connect with communities, friends, and businesses at any place and time.

Phly Inc. (a Delaware company based in New York City) is the company behind FLYY; the complete social metaverse rapidly changing the social network scene forever! Time to bring back the social aspect of a community and connect with each other in the best possible way!

We all know shared experiences are good for the soul. Flyy users can interact at various places across the world on this immersive go-to platform, offering pins across the city, with a discover page on what to eat, see, do, shop, and stay at all the hottest places. For individuals that have just moved to a big city, it can be awfully hard to find the local spots that are good, as well as keeping on top of where all their friends are going to. It takes time, trial, and error to find and save your favorite spots.

That problem is now resolved. Flyy suggests users to connect based on common movement habits, places they post on, tags, and interests. Joining in on the social scene has become seamless.

Flyy’s goal is to have you discover and share your favorite places & hidden gems with others in the community. Bored and unsure of where to go? Well fear not, Flyy gives you an effortless way to collect, remember and share all the places you love. Explore the 3D map and see what is popular each day with pins scattered all across the city of buzzing locations showing you what others have to say about it. No more mindlessly scrolling through social media feeds, time to discover the world around us with every tap of the way.

Flyy is also currently running a giveaway contest. Get your chance to WIN a PlayStation 5 or $200 Visa gift card by downloading their FREE mobile app and post your favorite pic or video of the place you like the most to enter the contest. The post with most likes wins! Will you be the lucky winner?

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine